Human Metabolome Technologies Inc. (6090)

Overview

Human Metabolome Technologies, Inc. stands out as a biotechnology company with a keen focus on developing cutting-edge metabolomics technologies and solutions. Established in 2003 and operating out of Tsuruoka, Japan, this innovative company has carved a niche for itself in the realms of drug discovery, diagnosis, and food production. With a commitment to advancing scientific research and application, Human Metabolome Technologies fosters collaboration with prestigious institutions like the Institute for Advanced Biosciences and Keio University. This partnership aims to further the development of metabolome analysis technology, showcasing the company's dedication to pushing the boundaries of scientific exploration and application in metabolomics.

Products and Services

Human Metabolome Technologies, Inc. offers a comprehensive suite of metabolomics analysis services and solutions tailored to meet a wide range of scientific and industrial needs. Each service is designed with precision to provide valuable insights across various applications, ensuring clients achieve their research and development goals effectively.

• Metabolome Analysis Services: At the core of its offerings, the company provides in-depth metabolome analysis to uncover the complete set of metabolites present in biological samples. This foundational service enables researchers to gain a comprehensive understanding of the metabolic profiles relevant to diseases, treatment effects, and nutritional statuses.
• Global Profiling: This service offers an exhaustive analysis of metabolites, presenting a broad overview of the metabolic state of a sample. Global profiling is crucial for identifying novel biomarkers and understanding complex metabolic changes.
• Targeted Assays: For more focused research requirements, targeted assays provide quantification of specific metabolites. This precise approach is pivotal in validating biomarkers and investigating targeted metabolic pathways.
• Flux Analysis: Understanding metabolic fluxes is essential for unraveling the dynamics of metabolism. Flux analysis services offered by the company enable researchers to track the flow of metabolites through metabolic pathways, offering insights into cellular function and metabolic disorders.
• Lipidomics: Focusing on the comprehensive study of cellular lipids, lipidomics services facilitate the exploration of lipid metabolism. This is particularly valuable for research in areas such as obesity, diabetes, and cardiovascular diseases.
• Development of Biomarkers: One notable achievement in this area is the identification of Phosphorylethanolamine as a biomarker for major depressive disorder, measurable in blood plasma. The development of such biomarkers is integral for advancing diagnostics and personalized medicine.

In addition to these services, Human Metabolome Technologies tailors its approach to support various applications, including cancer metabolism, metabolic flux analysis, infectious diseases, basic science research, preclinical and clinical studies, food and nutrition, and microbiome research. Through this broad yet specialized service offering, the company addresses the diverse needs of its clientele, ultimately contributing to scientific advancement and innovation in biotechnology.